Article
HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental Validation
2026-02-16
Abstract excerpt
<title>Abstract</title> <p> Background Lung adenocarcinoma (LUAD) represents the most prevalent pathological subtype of non-small cell lung cancer (NSCLC), a malignancy that accounts for 80–85% of all lung cancer cases. However, the expression profile of HILPDA and its functional significance in LUAD remain largely elusive. In this study, we sought to elucidate the regulatory mechanism of HILPDA in LUAD progres...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7ed0d6a-7f0b-5f93-b97d-190fffc47b98
- DOI
- 10.21203/rs.3.rs-8572177/v1
